These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20507089)

  • 21. Investigational anabolic therapies for osteoporosis.
    Trivedi R; Goswami R; Chattopadhyay N
    Expert Opin Investig Drugs; 2010 Aug; 19(8):995-1005. PubMed ID: 20629616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and structure-activity relationships of 3H-quinazolin-4-ones and 3H-pyrido[2,3-d]pyrimidin-4-ones as CXCR3 receptor antagonists.
    Storelli S; Verzijl D; Al-Badie J; Elders N; Bosch L; Timmerman H; Smit MJ; De Esch IJ; Leurs R
    Arch Pharm (Weinheim); 2007 Jun; 340(6):281-91. PubMed ID: 17562560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 1-Alkyl-4-phenyl-6-alkoxy-1H-quinazolin-2-ones: a novel series of potent calcium-sensing receptor antagonists.
    Widler L; Altmann E; Beerli R; Breitenstein W; Bouhelal R; Buhl T; Gamse R; Gerspacher M; Halleux C; John MR; Lehmann H; Kalb O; Kneissel M; Missbach M; Müller IR; Reidemeister S; Renaud J; Taillardat A; Tommasi R; Weiler S; Wolf RM; Seuwen K
    J Med Chem; 2010 Mar; 53(5):2250-63. PubMed ID: 20158186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioactivation of 2,3-diaminopyridine-containing bradykinin B1 receptor antagonists: irreversible binding to liver microsomal proteins and formation of glutathione conjugates.
    Tang C; Subramanian R; Kuo Y; Krymgold S; Lu P; Kuduk SD; Ng C; Feng DM; Elmore C; Soli E; Ho J; Bock MG; Baillie TA; Prueksaritanont T
    Chem Res Toxicol; 2005 Jun; 18(6):934-45. PubMed ID: 15962928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis.
    Brixen KT; Christensen PM; Ejersted C; Langdahl BL
    Basic Clin Pharmacol Toxicol; 2004 Jun; 94(6):260-70. PubMed ID: 15228497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcilytics: antagonists of the calcium-sensing receptor for the treatment of osteoporosis.
    Widler L
    Future Med Chem; 2011 Apr; 3(5):535-47. PubMed ID: 21526895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antagonists of the calcium receptor I. Amino alcohol-based parathyroid hormone secretagogues.
    Marquis RW; Lago AM; Callahan JF; Trout RE; Gowen M; DelMar EG; Van Wagenen BC; Logan S; Shimizu S; Fox J; Nemeth EF; Yang Z; Roethke T; Smith BR; Ward KW; Lee J; Keenan RM; Bhatnagar P
    J Med Chem; 2009 Jul; 52(13):3982-93. PubMed ID: 19492813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification in rat bile of glutathione conjugates of fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether, a nephrotoxic degradate of the anesthetic agent sevoflurane.
    Jin L; Davis MR; Kharasch ED; Doss GA; Baillie TA
    Chem Res Toxicol; 1996 Mar; 9(2):555-61. PubMed ID: 8839062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The calcium-sensing receptor in bone cells: a potential therapeutic target in osteoporosis.
    Marie PJ
    Bone; 2010 Mar; 46(3):571-6. PubMed ID: 19660583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioactivation of diclofenac in vitro and in vivo: correlation to electrochemical studies.
    Madsen KG; Skonberg C; Jurva U; Cornett C; Hansen SH; Johansen TN; Olsen J
    Chem Res Toxicol; 2008 May; 21(5):1107-19. PubMed ID: 18419141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NTP Technical Report on the metabolism, toxicity and predicted carcinogenicity of diazoaminobenzene (CAS No. 136-35-6).
    Ress NB;
    Toxic Rep Ser; 2002 Sep; (73):1-23, A1-C6. PubMed ID: 12370695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
    Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
    Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioactivation of estrone and its catechol metabolites to quinoid-glutathione conjugates in rat liver microsomes.
    Iverson SL; Shen L; Anlar N; Bolton JL
    Chem Res Toxicol; 1996 Mar; 9(2):492-9. PubMed ID: 8839054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolism and bioactivation of 3-methylindole by human liver microsomes.
    Yan Z; Easterwood LM; Maher N; Torres R; Huebert N; Yost GS
    Chem Res Toxicol; 2007 Jan; 20(1):140-8. PubMed ID: 17226936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 2-Substituted aminopyrido[2,3-d]pyrimidin-7(8H)-ones. structure-activity relationships against selected tyrosine kinases and in vitro and in vivo anticancer activity.
    Klutchko SR; Hamby JM; Boschelli DH; Wu Z; Kraker AJ; Amar AM; Hartl BG; Shen C; Klohs WD; Steinkampf RW; Driscoll DL; Nelson JM; Elliott WL; Roberts BJ; Stoner CL; Vincent PW; Dykes DJ; Panek RL; Lu GH; Major TC; Dahring TK; Hallak H; Bradford LA; Showalter HD; Doherty AM
    J Med Chem; 1998 Aug; 41(17):3276-92. PubMed ID: 9703473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An orally active calcium-sensing receptor antagonist that transiently increases plasma concentrations of PTH and stimulates bone formation.
    Kumar S; Matheny CJ; Hoffman SJ; Marquis RW; Schultz M; Liang X; Vasko JA; Stroup GB; Vaden VR; Haley H; Fox J; DelMar EG; Nemeth EF; Lago AM; Callahan JF; Bhatnagar P; Huffman WF; Gowen M; Yi B; Danoff TM; Fitzpatrick LA
    Bone; 2010 Feb; 46(2):534-42. PubMed ID: 19786130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid hit to lead evaluation of pyrazolo[3,4-d]pyrimidin-4-one as selective and orally bioavailable mGluR1 antagonists.
    Wang X; Kolasa T; El Kouhen OF; Chovan LE; Black-Shaefer CL; Wagenaar FL; Garton JA; Moreland RB; Honore P; Lau YY; Dandliker PJ; Brioni JD; Stewart AO
    Bioorg Med Chem Lett; 2007 Aug; 17(15):4303-7. PubMed ID: 17532216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The discovery of novel calcium sensing receptor negative allosteric modulators.
    Balan G; Bauman J; Bhattacharya S; Castrodad M; Healy DR; Herr M; Humphries P; Jennings S; Kalgutkar AS; Kapinos B; Khot V; Lazarra K; Li M; Li Y; Neagu C; Oliver R; Piotrowski DW; Price D; Qi H; Simmons HA; Southers J; Wei L; Zhang Y; Paralkar VM
    Bioorg Med Chem Lett; 2009 Jun; 19(12):3328-32. PubMed ID: 19442519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.